Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.2855
H.R.2855: To deem the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides to be approved.
About This Bill
- This bill was introduced in the 116th Congress
- This bill is primarily about health
- Introduced May 20, 2019
- Latest Major Action May 21, 2019
Bill Sponsor
Bill Version
- Introduced in House - May 20, 2019
Bill Summary
This bill provides for approval of the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides.
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Bill Actions
Date | Description |
---|---|
May 21, 2019 |
Referred to the Subcommittee on Health.
|
May 20, 2019 |
Referred to the House Committee on Energy and Commerce.
|
May 20, 2019 |
Introduced in the House by Steve King (R-Iowa) |